Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Chong Kun Dang Pharmaceutical"
Count: 252
Selected: 0
NCT IDTitle
NCT05050604A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients
NCT05041790A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
NCT04746287Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects
NCT05347576A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
NCT05335044Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-331 in Healthy Adult Volunteers
NCT04805606A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843
NCT05274880Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393
NCT04488900Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects
NCT05245084A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
NCT05238948CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects
NCT04987970A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg
NCT05193565Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
NCT05207761Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930
NCT05192356A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)
NCT05189288Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects
NCT05089279Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers
NCT05113693A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 in Healthy Volunteers Under Fed Conditions
NCT05108038A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
NCT05043467Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus
NCT04869800Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg
NCT03739125Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
NCT04830930A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers
NCT04628143A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
NCT04871646Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314
NCT04768673A Study to Investigate the PK and Safety of CKD-393
NCT04539652Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients
NCT04312698Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
NCT03794492Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome
NCT04952506Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers
NCT04694989A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)
NCT04673864A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
NCT04255589A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495
NCT04810676A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
NCT04548427Study to Evaluate the Efficacy and Safety of CKD-352
NCT04906798Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
NCT04906785Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT04883658A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
NCT04867720Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients
NCT04867200A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers
NCT04260438Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects
NCT04857177A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration
NCT04840745The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1
NCT04587206A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348
NCT04623021A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
NCT04706286Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393
NCT04703374A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04700709Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.
NCT03749356Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients
NCT04678388Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
NCT04676893Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects